Ameriprise’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Ameriprise’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-800	Closed	-$78K	–	3812
2019 Q3	$78K	Hold	800	–	–	﹤0.01%	3648
2019 Q2	$82K	Buy	+800	New	+$86.3K	﹤0.01%	3675

Ameriprise's ONCE Position: Q4 2019 in Review

Ameriprise sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 7,182 shares — an estimated $696K sold.

Ameriprise first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $18.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Ameriprise reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Ameriprise sold 7,182 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $696K.
Ameriprise first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
Ameriprise's Spark Therapeutics, Inc. Common Stock position peaked at $18.5M in Q3 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ameriprise's 13F filing for Q4 2019, filed 14 Feb 2020.